MMP16 and schizophrenia: GWAS data indicate that MMP16 may represent a vulnerability gene for SZ (Ma et al., 2018; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014), and increased IgG levels against MMP16 fragments were reported in plasma samples of people with SZ (Whelan et al., 2018).